Michael “Mike” Albert MD
@michaelalbertmd.bsky.social
Co-Founder, Chief Medical Officer @AccomplisHealth | Obesity & Cardiometabolic Medicine | Clinical Incretinology | Healthcare Futurist
🚨 New study from my research group and All of Us Research Program—270K+ adults—finds that Obesity is linked to a higher risk of 16 diseases.
Class 3 obesity = 11x risk of sleep apnea, 7.7x diabetes, 6.7x fatty liver. 51% of OSA cases may be due to obesity.
evidence.nejm.org/doi/10.1056/...
Class 3 obesity = 11x risk of sleep apnea, 7.7x diabetes, 6.7x fatty liver. 51% of OSA cases may be due to obesity.
evidence.nejm.org/doi/10.1056/...
March 25, 2025 at 5:10 PM
🚨 New study from my research group and All of Us Research Program—270K+ adults—finds that Obesity is linked to a higher risk of 16 diseases.
Class 3 obesity = 11x risk of sleep apnea, 7.7x diabetes, 6.7x fatty liver. 51% of OSA cases may be due to obesity.
evidence.nejm.org/doi/10.1056/...
Class 3 obesity = 11x risk of sleep apnea, 7.7x diabetes, 6.7x fatty liver. 51% of OSA cases may be due to obesity.
evidence.nejm.org/doi/10.1056/...
Not taking prescribed medicine can lead to complications. Skipping recommended vaccines increases your vulnerability to preventable diseases.
We often forget that choosing to do nothing doesn’t mean living risk-free—it simply means accepting a different set of risks.
We often forget that choosing to do nothing doesn’t mean living risk-free—it simply means accepting a different set of risks.
February 18, 2025 at 6:41 PM
Not taking prescribed medicine can lead to complications. Skipping recommended vaccines increases your vulnerability to preventable diseases.
We often forget that choosing to do nothing doesn’t mean living risk-free—it simply means accepting a different set of risks.
We often forget that choosing to do nothing doesn’t mean living risk-free—it simply means accepting a different set of risks.
In healthcare, the one who pays makes the rules.
To drive real change, you either have to forgo insurance and pay out-of-pocket or pass policies that shift power away from insurance companies.
Nothing will change until the payer dynamics change. This is a fact.
To drive real change, you either have to forgo insurance and pay out-of-pocket or pass policies that shift power away from insurance companies.
Nothing will change until the payer dynamics change. This is a fact.
February 17, 2025 at 7:02 PM
In healthcare, the one who pays makes the rules.
To drive real change, you either have to forgo insurance and pay out-of-pocket or pass policies that shift power away from insurance companies.
Nothing will change until the payer dynamics change. This is a fact.
To drive real change, you either have to forgo insurance and pay out-of-pocket or pass policies that shift power away from insurance companies.
Nothing will change until the payer dynamics change. This is a fact.
I’m working on a special podcast project for the obesity scientific community.
Do you have a favorite obesity-related podcast for healthcare and science professionals? Drop your recommendations below—I’d love to check them out.
Do you have a favorite obesity-related podcast for healthcare and science professionals? Drop your recommendations below—I’d love to check them out.
February 11, 2025 at 2:32 AM
I’m working on a special podcast project for the obesity scientific community.
Do you have a favorite obesity-related podcast for healthcare and science professionals? Drop your recommendations below—I’d love to check them out.
Do you have a favorite obesity-related podcast for healthcare and science professionals? Drop your recommendations below—I’d love to check them out.
“On Friday morning, the staffers at a half dozen U.S.-funded medical facilities in Sudan who care for severely malnourished children had a choice to make: Defy President Donald Trump’s order to immediately stop their operations or let…babies and toddlers die.” www.propublica.org/article/trum...
“People Will Die”: The Trump Administration Said It Lifted Its Ban on Lifesaving Humanitarian Aid. That’s Not True.
Organizations that provide vital care for desperate and vulnerable people around the world have been forced to halt operations, turn away patients and lay off staff. “I’ve never seen anything that sca...
www.propublica.org
February 1, 2025 at 3:26 PM
“On Friday morning, the staffers at a half dozen U.S.-funded medical facilities in Sudan who care for severely malnourished children had a choice to make: Defy President Donald Trump’s order to immediately stop their operations or let…babies and toddlers die.” www.propublica.org/article/trum...
📖 NEW from Me: The Weight of Promises
The Weight of Promises is an allegory about hope, manipulation, and the quiet power of seeing through the noise. If you’ve ever felt like your struggles were someone else’s profit, this story is for you.
👉 Read it here: medium.com/@MichaelAlbe...
The Weight of Promises is an allegory about hope, manipulation, and the quiet power of seeing through the noise. If you’ve ever felt like your struggles were someone else’s profit, this story is for you.
👉 Read it here: medium.com/@MichaelAlbe...
The Weight of Promises
Generate by Sora
medium.com
January 30, 2025 at 2:36 PM
📖 NEW from Me: The Weight of Promises
The Weight of Promises is an allegory about hope, manipulation, and the quiet power of seeing through the noise. If you’ve ever felt like your struggles were someone else’s profit, this story is for you.
👉 Read it here: medium.com/@MichaelAlbe...
The Weight of Promises is an allegory about hope, manipulation, and the quiet power of seeing through the noise. If you’ve ever felt like your struggles were someone else’s profit, this story is for you.
👉 Read it here: medium.com/@MichaelAlbe...
Your obligatory reminder to be careful with chiropractors:
Gym-Goer, 29, Dies After Getting Her Neck Adjusted by Chiropractor: ‘Tragic Case’
people.com/woman-29-die...
Gym-Goer, 29, Dies After Getting Her Neck Adjusted by Chiropractor: ‘Tragic Case’
people.com/woman-29-die...
Gym-Goer, 29, Dies After Getting Her Neck Adjusted by Chiropractor: ‘Tragic Case’
Joanna Kowalczyk died in October 2021 after she suffered acute arterial dissections at the base of her skull and neck, which was also the exact location where she received chiropractic treatment.
people.com
January 30, 2025 at 1:55 AM
Your obligatory reminder to be careful with chiropractors:
Gym-Goer, 29, Dies After Getting Her Neck Adjusted by Chiropractor: ‘Tragic Case’
people.com/woman-29-die...
Gym-Goer, 29, Dies After Getting Her Neck Adjusted by Chiropractor: ‘Tragic Case’
people.com/woman-29-die...
FDA Violations Rock the Compound Tirzepatide and Semaglutide World
- -
Great ongoing coverage by @onthepen.bsky.social. Give him a follow.
www.onthepen.com/post/fda-vio...
- -
Great ongoing coverage by @onthepen.bsky.social. Give him a follow.
www.onthepen.com/post/fda-vio...
FDA Violations Rock the Compound Tirzepatide and Semaglutide World
The FDA has issued a warning letter to ProRx, LLC, outlining a series of violations that suggest the outsourcing facility has been operating
www.onthepen.com
January 29, 2025 at 7:38 PM
FDA Violations Rock the Compound Tirzepatide and Semaglutide World
- -
Great ongoing coverage by @onthepen.bsky.social. Give him a follow.
www.onthepen.com/post/fda-vio...
- -
Great ongoing coverage by @onthepen.bsky.social. Give him a follow.
www.onthepen.com/post/fda-vio...
Big News! The FDA has officially approved Novo Nordisk’s Ozempic to treat chronic kidney disease (CKD) in patients with type 2 diabetes (T2D), expanding its already critical role in managing metabolic health.
www.cnbc.com/2025/01/28/n...
www.cnbc.com/2025/01/28/n...
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.
www.cnbc.com
January 28, 2025 at 11:44 PM
Big News! The FDA has officially approved Novo Nordisk’s Ozempic to treat chronic kidney disease (CKD) in patients with type 2 diabetes (T2D), expanding its already critical role in managing metabolic health.
www.cnbc.com/2025/01/28/n...
www.cnbc.com/2025/01/28/n...
He’s making little effort to dispel criticism linking him to far-right, neo-Nazi, and modern eugenics ideologies.
January 26, 2025 at 5:13 PM
He’s making little effort to dispel criticism linking him to far-right, neo-Nazi, and modern eugenics ideologies.
Our new vitamins & supplements are here! 🌟 Crafted for bariatric patients and GLP-1 weight loss journeys, they’re 3rd-party tested and made in a certified GMP facility. Shop now: shop.accomplish.health.
Accomplish Health
Accomplish Health
shop.accomplish.health
January 21, 2025 at 3:56 PM
Our new vitamins & supplements are here! 🌟 Crafted for bariatric patients and GLP-1 weight loss journeys, they’re 3rd-party tested and made in a certified GMP facility. Shop now: shop.accomplish.health.
Wow, TikTok was a real one till the very end. #tiktokban #blackout
January 19, 2025 at 5:06 AM
Wow, TikTok was a real one till the very end. #tiktokban #blackout
STEP UP Trial Top-lin eResults
Novo Nordisk’s STEP UP trial shows semaglutide 7.2 mg achieved 20.7% weight loss with adherence and 18.7% on average over 72 weeks. 33% of participants lost more than 25% of their weight, outperforming semaglutide 2.4 mg and placebo, with a similar safety profile.
Novo Nordisk’s STEP UP trial shows semaglutide 7.2 mg achieved 20.7% weight loss with adherence and 18.7% on average over 72 weeks. 33% of participants lost more than 25% of their weight, outperforming semaglutide 2.4 mg and placebo, with a similar safety profile.
January 17, 2025 at 1:39 PM
STEP UP Trial Top-lin eResults
Novo Nordisk’s STEP UP trial shows semaglutide 7.2 mg achieved 20.7% weight loss with adherence and 18.7% on average over 72 weeks. 33% of participants lost more than 25% of their weight, outperforming semaglutide 2.4 mg and placebo, with a similar safety profile.
Novo Nordisk’s STEP UP trial shows semaglutide 7.2 mg achieved 20.7% weight loss with adherence and 18.7% on average over 72 weeks. 33% of participants lost more than 25% of their weight, outperforming semaglutide 2.4 mg and placebo, with a similar safety profile.
The Definition of Obesity Is Changing And What It Means for You ⤵️
medium.com/@MichaelAlbe...
medium.com/@MichaelAlbe...
The Future Definition of Obesity: Rethinking an Outdated Paradigm
Generated by DALL-E
medium.com
December 21, 2024 at 1:57 PM
The Definition of Obesity Is Changing And What It Means for You ⤵️
medium.com/@MichaelAlbe...
medium.com/@MichaelAlbe...
🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟
www.fda.gov/news-events/...
www.fda.gov/news-events/...
December 20, 2024 at 10:34 PM
🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟
www.fda.gov/news-events/...
www.fda.gov/news-events/...
BREAKING: Topline results from REDEFINE-1, a Ph3 trial for CagriSema, highlight the novel GLP-1 RA/Amylin RA combo achieving 22.7% weight loss (when paired with diet & exercise) over 68 weeks.
CagriSema demonstrates weight loss efficacy comparable to Tirzepatide.
www.novonordisk.com/news-and-med...
CagriSema demonstrates weight loss efficacy comparable to Tirzepatide.
www.novonordisk.com/news-and-med...
December 20, 2024 at 12:45 PM
BREAKING: Topline results from REDEFINE-1, a Ph3 trial for CagriSema, highlight the novel GLP-1 RA/Amylin RA combo achieving 22.7% weight loss (when paired with diet & exercise) over 68 weeks.
CagriSema demonstrates weight loss efficacy comparable to Tirzepatide.
www.novonordisk.com/news-and-med...
CagriSema demonstrates weight loss efficacy comparable to Tirzepatide.
www.novonordisk.com/news-and-med...
🚨BREAKING: FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage www.cnbc.com/2024/12/19/f...
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
www.cnbc.com
December 19, 2024 at 3:10 PM
🚨BREAKING: FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage www.cnbc.com/2024/12/19/f...
USC’s Schaeffer Center critiques the CBO’s obesity drug analysis, projecting $1T in benefits over 10 years and $4T over 30 years from comprehensive treatment.
healthpolicy.usc.edu/article/cbo-...
healthpolicy.usc.edu/article/cbo-...
The CBO Report on Medicare and Anti-Obesity Medications Should Not Be the Final Word
The highly anticipated report contains clues on how Congress may come to a different view on medications like Wegovy and Zepbound.
healthpolicy.usc.edu
December 19, 2024 at 2:57 AM
USC’s Schaeffer Center critiques the CBO’s obesity drug analysis, projecting $1T in benefits over 10 years and $4T over 30 years from comprehensive treatment.
healthpolicy.usc.edu/article/cbo-...
healthpolicy.usc.edu/article/cbo-...
The hyperconsumerization of healthcare has fostered a landscape where superficial medicine often thrives. In this piece, I explore the roots of this problem and propose meaningful pathways forward.
medium.com/@MichaelAlbe...
medium.com/@MichaelAlbe...
The Quick Fix Epidemic: How Superficial Medicine Is Failing Our Health
Why chasing symptoms, profits, and convenience is costing us real, lasting wellness.
medium.com
December 17, 2024 at 6:46 PM
The hyperconsumerization of healthcare has fostered a landscape where superficial medicine often thrives. In this piece, I explore the roots of this problem and propose meaningful pathways forward.
medium.com/@MichaelAlbe...
medium.com/@MichaelAlbe...
Accomplish and ATA Forge Partnership to Deliver Comprehensive Medical Weight Loss and Mental Health Services for Patients with Obesity
I'm very excited about this partnership to enhance the mental healthcare of our patients living with obesity.
www.accomplish.health/blog/accompl...
I'm very excited about this partnership to enhance the mental healthcare of our patients living with obesity.
www.accomplish.health/blog/accompl...
Accomplish Partners with ATA to Transform Bariatric Care | Accomplish Health — Accomplish Health
Accomplish Health and ATA unite to provide comprehensive medical weight loss and mental health services for bariatric patients, combining advanced treatments with dedicated psychological support.
www.accomplish.health
December 10, 2024 at 4:27 PM
Accomplish and ATA Forge Partnership to Deliver Comprehensive Medical Weight Loss and Mental Health Services for Patients with Obesity
I'm very excited about this partnership to enhance the mental healthcare of our patients living with obesity.
www.accomplish.health/blog/accompl...
I'm very excited about this partnership to enhance the mental healthcare of our patients living with obesity.
www.accomplish.health/blog/accompl...
🚨Breaking: Lilly’s Zepbound® (tirzepatide) outperforms Wegovy® (semaglutide) in weight loss trial over 72 weeks
SURMOUNT-5 Top-line results:
🔹 Zepbound: 20.2% avg. weight loss (50.3 lbs)
Vs.
🔹 Wegovy: 13.7% avg. weight loss (33.1 lbs)
SURMOUNT-5 Top-line results:
🔹 Zepbound: 20.2% avg. weight loss (50.3 lbs)
Vs.
🔹 Wegovy: 13.7% avg. weight loss (33.1 lbs)
December 4, 2024 at 1:58 PM
🚨Breaking: Lilly’s Zepbound® (tirzepatide) outperforms Wegovy® (semaglutide) in weight loss trial over 72 weeks
SURMOUNT-5 Top-line results:
🔹 Zepbound: 20.2% avg. weight loss (50.3 lbs)
Vs.
🔹 Wegovy: 13.7% avg. weight loss (33.1 lbs)
SURMOUNT-5 Top-line results:
🔹 Zepbound: 20.2% avg. weight loss (50.3 lbs)
Vs.
🔹 Wegovy: 13.7% avg. weight loss (33.1 lbs)
🚨 Big News for Oregon! 🚨
Accomplish Health is now LIVE and accepting patients in the Beaver State! 🌟
Don’t wait to start your journey toward better health and confidence. Sign up here: www.accomplish.health/start
Accomplish Health is now LIVE and accepting patients in the Beaver State! 🌟
Don’t wait to start your journey toward better health and confidence. Sign up here: www.accomplish.health/start
December 3, 2024 at 8:38 PM
🚨 Big News for Oregon! 🚨
Accomplish Health is now LIVE and accepting patients in the Beaver State! 🌟
Don’t wait to start your journey toward better health and confidence. Sign up here: www.accomplish.health/start
Accomplish Health is now LIVE and accepting patients in the Beaver State! 🌟
Don’t wait to start your journey toward better health and confidence. Sign up here: www.accomplish.health/start
GLP-1 Medications Q&A
www.accomplish.health/blog/glp1-me...
www.accomplish.health/blog/glp1-me...
GLP-1 Medications Q&A — Accomplish Health
GLP-1 medications are FDA-approved drugs that help treat obesity by managing appetite and blood sugar levels. While medications like Wegovy, Saxenda, and Zepbound are specifically approved for weight ...
www.accomplish.health
December 3, 2024 at 3:59 PM
GLP-1 Medications Q&A
www.accomplish.health/blog/glp1-me...
www.accomplish.health/blog/glp1-me...
When there is substantial evidence that food companies have contributed to the development of obesity—which seems inevitable—could we sue them and force them to subsidize obesity care programs?
December 1, 2024 at 2:44 PM
When there is substantial evidence that food companies have contributed to the development of obesity—which seems inevitable—could we sue them and force them to subsidize obesity care programs?
Liraglutide Impacts Iron Homeostasis in a Murine Model of Hereditary Hemochromatosis
academic.oup.com/endo/article...
academic.oup.com/endo/article...
Liraglutide Impacts Iron Homeostasis in a Murine Model of Hereditary Hemochromatosis
Abstract. Classic hereditary hemochromatosis (HH) is an autosomal recessive iron-overload disorder resulting from loss-of-function mutations of the HFE gen
academic.oup.com
November 30, 2024 at 9:33 PM
Liraglutide Impacts Iron Homeostasis in a Murine Model of Hereditary Hemochromatosis
academic.oup.com/endo/article...
academic.oup.com/endo/article...